| Health / Medical Topics |
Ancitabine
A cytarabine congener prodrug with antineoplastic activity. Upon administration, ancitabine is slowly hydrolyzed into cytarabine, which is converted to the active triphosphate form and competes with deoxycytidine triphosphate for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA and RNA polymerases, resulting in a decrease in cell growth. Compared to cytarabine, a more prolonged, consistent cytarabine-mediated therapeutic effect may be achieved with ancitabine because of the slow hydrolytic conversion of ancitabine to cytarabine. (NCI Thesaurus)
YOU MAY ALSO LIKE
In a clinical trial, a medical test on a patient that is not a part of the original study design.
A study that is secondary to another study.
DNA recovered from ancient biological material (e.g., archaeological and historical skeletal material, mummified tissues, preserved plant remains, ice and permafrost cores). …
Anchoring junctions typically are observed as "spot welds" between cells in many types of epithelia. Detail structures can be seen only with…
An assay to determine the ability of cells to grow unattached to a substrate. It is an indication that the cells have…
Resistance to activation force.
